Çiğdem Karaca

Çiğdem Karaca

Auto-generated profile, based on publicly available information

Çiğdem Karaca

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Hacettepe University, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
ÇKÇ. Karaca
Ç. Karaca
NEN. Er
N. Er
AGA. Gülşahı
A. Gülşahı
OKO.T. Köseoğlu
O.T. Köseoğlu


1 January 2018 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
CKC Karaca
C Karaca
KDKa Dere
Ka Dere
NEN Er
N Er
AAA Aktas
A Aktas
ETE Tosun
E Tosun
AUA Usubutun
A Usubutun
Background: Odontogenic keratocysts have been reported with high recurrence rates in the literature so various treatment modalities from simple enucleation to resection have been performed to achieve the cure. The purpose of this retrospective study was to investigate the recurrence rate of odontogenic keratocysts (OKCs) treated by enucleation and peripheral ostectomy. Material and Methods: An electronic search of the database of the Hacettepe University, Faculty of Medicine, Department of Pathology, was undertaken to identify patients histologically diagnosed with OKCs treated at Department of Oral and Maxillofacial Surgery between 2001 and 2015. Results: In total, 81 patients were studied. The mean age at the time of diagnosis was 42 years, and the male: female ratio was 1:0.7. OKCs were located primarily in the posterior mandibular region (41%). Twenty-seven patients were re-examined to determine the recurrence rate. The mean follow-up period was 5 years (range, 1-12 years). The recurrence rate was 14.8%. The relationship between location of the lesion and recurrence was not statistically significant (p = 0.559). There was also no statistically significant relation between the recurrence rate and treatment option of teeth involved in the lesion (p = 0.579). Conclusions: The authors conclude that treatment of OKCs by enucleation with peripheral ostectomy is associated with minimal morbidity and is preferred over other aggressive treatment modalities. Meticulous radiographic examination and careful surgical resection may decrease the recurrence rate of OKCs.

1 February 2021 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
DBD.Uçar Boyacıgil
D.Uçar Boyacıgil
NEN. Er
N. Er
ÇKÇ. Karaca
Ç. Karaca
OKO. Koç
O. Koç

1 April 2013 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
NENuray Er
Nuray Er
HTHakan Yusuf Tuncer
Hakan Yusuf Tuncer
ÇKÇiğdem Karaca
Çiğdem Karaca
SÇSeçil Çopuroğlu
Seçil Çopuroğlu

16 July 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IŞIrem Durmaz Şahin
Irem Durmaz Şahin
MCMichael S. Christodoulou
Michael S. Christodoulou
EGEce Akhan Guzelcan
Ece Akhan Guzelcan
AKAltay Koyas
Altay Koyas
CKCigdem Karaca
Cigdem Karaca
RCRengul Cetin-Atalay
Rengul Cetin-Atalay
Hepatocellular carcinoma (HCC) ranks as the fifth most common and the second deadliest cancer worldwide. HCC is extremely resistant to the conventional chemotherapeutics. Hence, it is vital to develop new treatment options. Chalcones were previously shown to have anticancer activities in other cancer types. In this study, 11 chalcones along with quercetin, papaverin, catechin, Sorafenib and 5FU were analyzed for their bioactivities on 6 HCC cell lines and on dental pulp stem cells (DPSC) which differentiates into hepatocytes, and is used as a model for untransformed control cells. 3 of the chalcones (1, 9 and 11) were selected for further investigation due to their high cytotoxicity against liver cancer cells and compared to the other clinically established compounds. Chalcones did not show significant bioactivity ( $$\hbox {IC}_{50}>20\upmu \hbox {M}$$IC50>20μM ) on dental pulp stem cells. Cell cycle analysis revealed that these 3 chalcone-molecules induced SubG1/G1 arrest. Akt protein phosphorylation was inhibited by these molecules in PTEN deficient, drug resistant, mesenchymal like Mahlavu cells leading to the activation of p21 and the inhibition of NF $$ \kappa $$κ B-p65 transcription factor. Hence the chalcones induced apoptotic cell death pathway through NF $$ \kappa $$κ B-p65 inhibition. On the other hand, these molecules triggered p21 dependent activation of Rb protein and thereby inhibition of cell cycle and cell growth in liver cancer cells. Involvement of PI3K/Akt pathway hyperactivation was previously described in survival of liver cancer cells as carcinogenic event. Therefore, our results indicated that these chalcones can be considered as candidates for liver cancer therapeutics particularly when PI3K/Akt pathway involved in tumor development.